The New England Biotech Association (NEBA) is a coalition of biotechnology companies, academic institutions, pharmaceutical companies, and trade organizations from all six New England States.
NEBA serves as a regional policy and public affairs voice for the biotechnology and biopharmaceutical industry.[1]
NEBA is a non-profit, member driven organization, with over 600 members.[2]
The Chairman of NEBA is Paul Pescatello, Director of Connecticut United for Research Excellence -(CURE.) [3]
In 2010, NEBA advocated against measures that would harm the biotechnology industry in Maine [permanent dead link] and other New England states. The organization also launched a website www.MassRxHelp.org to help consumers save money on prescription medications.[4][5]
External links
editReferences
edit- ^ "Opportunities and challenges face biotech companies outside of Boston - Mass High Tech Business News". Archived from the original on 2012-02-12. Retrieved 2008-11-11.
- ^ "Latest News". MarketWatch. Retrieved 2024-02-16.
- ^ "CURE". www.curenet.org. Retrieved 2024-02-16.
- ^ "Pharmacists seek OK for discounts on co-pays - BostonHerald.com". Archived from the original on 2011-09-05. Retrieved 2010-12-15.
- ^ "Industry, lawmakers rally for drug coupons - Boston Business Journal". Archived from the original on 2012-10-26.